Stock IMR IMRICOR MEDICAL SYSTEMS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Imricor Medical Systems, Inc.

Equities

IMR

AU0000054942

Market Closed - Australian S.E.
Other stock markets
 02:10:52 2024-05-31 am EDT 		5-day change 1st Jan Change
0.485 AUD +1.04% Intraday chart for Imricor Medical Systems, Inc. +8.99% -14.91%
May. 15 Imricor Medical Systems, Inc. to Commence 2 Clinical Trials, VISABL-AFL and VISABL-VT CI
May. 15 Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Imricor Medical Systems, Inc. to Commence 2 Clinical Trials, VISABL-AFL and VISABL-VT
Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call
Imricor Medical Systems' VISABL-AFL Trial Receives Final Clearance from Swissmedic
Imricor Medical Systems Announces Release of Certain Stocks from Voluntary Escrow
Transcript : Imricor Medical Systems, Inc., Q1 2024 Earnings Call, Apr 30, 2024
Imricor Medical Systems Secures First Catheter Order from Croatia's Dubrava University Hospital
Mining, Healthcare Stocks Lift Australian Benchmark
Imricor Medical Systems Gains Approval for Clinical Trial at Cardiovascular Institute of South Paris; Shares Up 7%
Amsterdam University Medical Center Resumes Atrial Flutter Procedures with Imricor's NorthStar Mapping System
Imricor Medical Systems Completes AU$6.4 Million Shortfall Share Issue
Imricor Medical Systems' NorthStar 3D Mapping System Obtains Approval for Use in VISABL-AFL Trial
Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call
Imricor Medical Systems Secures Ethics Approval for Imaging Device Trial; Shares Rise 4%
Imricor Medical Systems' VISABL-AFL Trial Obtains Lausanne University Hospital Ethics Approval; Shares Up 8%
Imricor's Diagnostic Catheter Granted CE Mark Approval for European Market Sales; Shares Decline 4%
Transcript : Imricor Medical Systems, Inc., 2023 Earnings Call, Mar 05, 2024
Imricor Medical Systems' Loss Widens in 2023; Shares Down 8%
Imricor Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Imricor Medical Systems Plans Up to AU$15 Million Placement, Entitlement Offer
Imricor Medical Systems Secures Approval to Start US Medical Device Trial
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMR Stock
  4. News Imricor Medical Systems, Inc.
  5. Other languages